Trade MBX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
MBX Biosciences, Inc. (MBX) is trading at US$59.02, down 3.15% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$3.19B. Over the past 52 weeks, MBX has traded between US$9.64 and US$72.64. On Syfe you can trade MBX with $0 commission and add it to your watchlist.
| Previous close | US$60.94 |
|---|---|
| Market cap | US$3.19B |
| 52-week range | US$9.64 – US$72.64 |
| Volume | 306.2K |
| Exchange | US |
Add to Watchlist
Set Price Alert
MBX Biosciences, Inc.
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.
Year: 2024
Truist Adjusts Price Target on MBX Biosciences to $88 From $70, Maintains Buy Rating
Aug 10, 10:11 AM · MT Newswires
MBX Biosciences Shares Lower After Q2 Loss Widens
Aug 6, 2:40 PM · MT Newswires
--Earnings Flash (MBX) MBX Biosciences Posts Q2 Net Loss $0.78 a Share, vs. FactSet Est of $0.63 Loss
Aug 6, 12:12 PM · MT Newswires
MBX Biosciences Appoints Steve Hoerter as CEO; Kent Hawryluk Steps Down
Jul 13, 8:39 PM · MT Newswires
MBX Biosciences, Inc. (MBX) stock is trading at US$59.02, -3.15% from the previous close of US$60.94.
The market cap for MBX Biosciences, Inc. (MBX) stock is approximately US$3.19B.
The 52-week high for MBX Biosciences, Inc. (MBX) stock is US$72.64.
The 52-week low for MBX Biosciences, Inc. (MBX) stock is US$9.64.
MBX Biosciences, Inc. (MBX) does not currently pay a dividend.
Stay on top of MBX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
